Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK, $0.0001 PAR VALUE PER SHARE
-
Shares outstanding
-
5.09M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
535K
-
Shares change
-
+486K
-
Total reported value, excl. options
-
$1.89M
-
Value change
-
+$1.72M
-
Number of buys
-
15
-
Price
-
$3.54
Significant Holders of Matinas BioPharma Holdings, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE (MTNB) as of Q3 2024
16 filings reported holding MTNB - Matinas BioPharma Holdings, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE as of Q3 2024.
Matinas BioPharma Holdings, Inc. - COMMON STOCK, $0.0001 PAR VALUE PER SHARE (MTNB) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 535K shares
of 5.09M outstanding shares and own 10.52% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (186K shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (129K shares), Sargent Investment Group, LLC (80.2K shares), BlackRock, Inc. (49.7K shares), GEODE CAPITAL MANAGEMENT, LLC (46.7K shares), Squarepoint Ops LLC (20.6K shares), STATE STREET CORP (15.3K shares), UBS Group AG (3.43K shares), WELLS FARGO & COMPANY/MN (1.1K shares), and BANK OF AMERICA CORP /DE/ (1.02K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.